Effect of vitamin A supplementation on cause-specific mortality in women of reproductive age in Ghana: a secondary analysis from the ObaapaVitA trial
Lisa Hurt, Augustinus ten Asbroek, Seeba Amenga-Etego, Charles Zandoh, Samuel Danso, Karen Edmond, Chris Hurt, Charlotte Tawiah, Zelee Hill, Justin Fenty, Seth Owusu-Agyei, Oona M Campbell & Betty R Kirkwood
Volume 91, Number 1, January 2013, 19-27
Table 5. Age-specific all-cause and cause-specific mortality rates among women enrolled in the ObaapaVitA trial, Ghana, 2000–2008
| Parameter | Age (years) |
||||
|---|---|---|---|---|---|
| < 20 | 20–24 | 25–29 | 30–34 | ≥ 35 | |
| Person–years of follow-up | 108 989 | 144 522 | 132 363 | 108 226 | 186 870 |
| Deaths,a by cause:b | |||||
| All causes | 315 | 306 | 483 | 572 | 585 |
| Pregnancy-related | 49 | 57 | 73 | 67 | 37 |
| Infectious diseases | 99 | 110 | 230 | 265 | 234 |
| Neoplasms | 3 | 10 | 10 | 18 | 33 |
| Circulatory diseases | 19 | 9 | 19 | 35 | 49 |
| Injuries | 16 | 12 | 19 | 20 | 21 |
| Other known causes | 50 | 44 | 51 | 56 | 77 |
| Uncertain or unknown cause | 86 | 73 | 100 | 122 | 141 |
| Pregnancy-related deathsc | 422 | 293 | 339 | 402 | 549 |
a Per 100 000 person–years.
b As a consequence of rounding, the rates of cause-specific mortality do not exactly equal the corresponding all-cause mortality rate when they are added together.
c Per 100 000 pregnancies.